The methionine synthase (MTR) gene polymorphism A2756G has been linked to the risk of developing breast cancer, but the available results were inconsistent and underpowered. To derive a more precise estimation of the association between A2756G and breast cancer risk, an updated meta-analysis of 16 available studies with 9866 cases and 11,702 controls estimating the association between MTR A2756G and breast cancer risk was conducted. The quality of these studies was generally good except 2 studies with a lowest score 4 according to the Newcastle-Ottawa Scale (NOS). The results suggested that there is no significant association between A2756G and breast cancer risk in overall results. In the stratified analysis by ethnicity, source of controls (population or hospital-based), Hardy-Weinberg equilibrium (HWE) in controls, sample size (≥1000 and <1000 subjects), and menopausal status, the 2756G allele was associated with a decreased risk in Caucasians, PB (population-based) subgroup, and large studies. But the associations disappeared after removing the studies not in HWE. On the contrary, an increased risk was found in small studies. In conclusion, the findings suggest that MTR A2756G polymorphism is not associated with altered susceptibility to breast cancer, while the observed decreased risk in Caucasians, PB subgroup, and large studies and increased risk in small studies may be due to selection bias or other unknown factors.
Keywords: A2756G; Breast cancer; CI; HB; HWE; Hardy–Weinberg equilibrium; MALDI-TOF-MS; MTR; Meta-analysis; NOS; Newcastle–Ottawa Scale; OR; PB; PCR-RFLP; Polymorphism; SNP; Susceptibility; confidence interval; hospital-based; matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; methionine synthase; odds ratio; polymerase chain reaction-restriction fragment length polymorphism; population-based; single nucleotide polymorphism, LD, linkage disequilibrium.
© 2013 Elsevier B.V. All rights reserved.